Skip to content

Clinical trials

Phase 3 Lung Neoplasms trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 3 Country / region: Hungary Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20061
20072
20081
20101
20121
20131
20142
20151
20161
20191
20202
20211
20222
20232
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting8
Active, not recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Bristol-Myers Squibb2
Eli Lilly and Company2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Pfizer2
Achieve Life Sciences1
Amgen1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms29
Carcinoma, Non-Small-Cell Lung20
Carcinoma4
Small Cell Lung Carcinoma4
Lung Diseases3
Neoplasm Metastasis3
Neoplasms3
Bronchial Neoplasms2
Neoplasms by Site2
Respiratory Tract Diseases2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.